The biodistribution of 5-[18F]fluoropyrazinamide in Mycobacterium tuberculosis-infected mice determined by positron emission tomography

18F-Labeling of Arenes and Heteroarenes for Applications in Positron Emission Tomography

(2016) Sean Preshlock et al.   CHEMICAL REVIEWS

Mouse model of pulmonary cavitary tuberculosis and expression of matrix metalloproteinase-9

(2016) Alvaro A. Ordonez et al.   Disease Models & Mechanisms

Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in Mycobacterium tuberculosis Infected C3HeB/FeJ Mice

(2016) Scott M. Irwin et al.   ACS Infectious Diseases

Determination of [11C]Rifampin Pharmacokinetics within Mycobacterium tuberculosis-Infected Mice by Using Dynamic Positron Emission Tomography Bioimaging

(2015) Vincent P. DeMarco et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Imaging Chronic Tuberculous Lesions Using Sodium [18F]Fluoride Positron Emission Tomography in Mice

(2015) Alvaro A. Ordonez et al.   MOLECULAR IMAGING AND BIOLOGY

The association between sterilizing activity and drug distribution into tuberculosis lesions

(2015) Brendan Prideaux et al.   NATURE MEDICINE

Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives

(2015) Laura E. Via et al.   ACS Infectious Diseases

Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography

(2014) E. A. Weinstein et al.   Science Translational Medicine

Host Targeted Activity of Pyrazinamide in Mycobacterium tuberculosis Infection

(2013) Claudia Manca et al.   PLoS One

Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis

(2013) Shuo Zhang et al.   Emerging Microbes & Infections

Noninvasive Determination of 2-[18F]-Fluoroisonicotinic Acid Hydrazide Pharmacokinetics by Positron Emission Tomography in Mycobacterium tuberculosis-Infected Mice

(2012) E. A. Weinstein et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pyrazinamide Susceptibility Testing in Mycobacterium tuberculosis: a Systematic Review with Meta-Analyses

(2011) Kwok Chiu Chang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mouse Model of Necrotic Tuberculosis Granulomas Develops Hypoxic Lesions

(2011) Jamie Harper et al.   JOURNAL OF INFECTIOUS DISEASES

Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis

(2011) W. Shi et al.   SCIENCE

Mutually Exclusive Genotypes for Pyrazinamide and 5-Chloropyrazinamide Resistance Reveal a Potential Resistance-Proofing Strategy

(2010) A. D. Baughn et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Noninvasive Pulmonary [18F]-2-Fluoro-Deoxy-D-Glucose Positron Emission Tomography Correlates with Bactericidal Activity of Tuberculosis Drug Treatment

(2009) S. L. Davis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pyrazinamide

(2008)   TUBERCULOSIS